• About Us
• Facilities

Chrono Therapeutics Inc. receives notification from the European Patent Office that an additional key patent for CHRONODOSE™ has been granted. This new patent grant affirms the novelty of CTI’s technology and believes it will considerably reduce any potential risk to the CTI group.

Chrono Therapeutics Inc. is featured in Transdermal Magazine.

(SEE PAGE 6)

Download The PDF